EBOS Group Limited (ASX:EBO)
Australia · Delayed Price · Currency is AUD 24.86
+0.12 (0.49%)
Nov 14, 2025, 10:05 AM AEST
EBOS Group Market Cap
EBOS Group has a market cap or net worth of 5.08 billion as of November 13, 2025. Its market cap has decreased by -22.41% in one year.
Market Cap
5.08B
Enterprise Value
6.41B
Revenue
12.27B
Ranking
n/a
PE Ratio
23.62
Stock Price
24.86
Market Cap Chart
Since August 30, 1999, EBOS Group's market cap has increased from 37.66M to 5.08B, an increase of 13,391.13%. That is a compound annual growth rate of 20.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 5.08B | -22.14% |
| Dec 31, 2024 | 6.53B | 3.20% |
| Dec 29, 2023 | 6.33B | -18.95% |
| Dec 30, 2022 | 7.81B | 9.56% |
| Dec 31, 2021 | 7.12B | 62.70% |
| Dec 31, 2020 | 4.38B | 16.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.55B |
| Pro Medicus | 26.70B |
| Cochlear | 18.10B |
| Sonic Healthcare | 10.44B |
| Ramsay Health Care | 7.19B |
| Ansell | 5.24B |
| Telix Pharmaceuticals | 5.07B |
| Mesoblast | 2.96B |